Iconic Labs : Result of AGM

RNS Number : 3979Y

Iconic Labs PLC

31 December 2019

31 December 2019

Iconic Labs Plc ("Iconic Labs" or the "Company")

Results of AGM

Iconic Labs plc (AIM: ICON), a multi-divisional new media and technology business, advises that it held its Annual General Meeting ("AGM") yesterday.

All resolutions were duly passed on a poll vote, with the sole exception of resolution 11, which was a special resolution requiring a 75% vote in favour and which was not passed (empowering Directors to allot shares for cash without first offering them to existing shareholders on a pro-rata basis). Resolution 4 was withdrawn. Details of the proxy voting are shown in the table below.

Ordinary	Votes For	%	Votes	%	Votes Total	Votes
resolutions			Against			Withheld
1 Annual	236,777,016	91%	2,373,736	1%	259,450,389	20,299,637
report and
accounts
2 Directors'	234,021,286	90%	5,129,466	2%	259,450,389	20,299,637
remuneration
report
3 Directors'	228,408,825	88%	10,741,927	4%	259,450,389	20,299,637
remuneration
policy
4
Reappointment			Resolution withdrawn
of directors
(David Sefton)
5
Reappointment	236,335,124	91%	2,815,628	1%	259,450,389	20,299,637
of directors
(John Quinlan)
6
Reappointment	236,335,124	91%	2,815,628	1%	259,450,389	20,299,637
of directors
(Liam
Harrington)
7
Reappointment	236,335,124	91%	2,815,628	1%	259,450,389	20,299,637
of directors
(Sam Asante)
8 Re-	236,777,016	91%	2,373,736	1%	259,450,389	20,299,637
appointment of
auditors
9	236,777,016	91%	2,373,736	1%	259,450,389	20,299,637
Remuneration
of auditors
10 Directors'
authority to	144,572,663	56%	114,877,726	44%	259,450,389	-
allot shares on
a pro-rata
basis
Special
Resolutions
11 Empowering
the directors'	143,958,825	55%	115,491,564	45%	259,450,389	-
to disapply
statutory pre-
emption rights
12 Purchase by
the Company	229,164,555	88%	10,036,197	4%	259,450,389	20,299,637
of its own
shares

The full text of each of the resolutions is set out in the Notice of AGM, available on the Company's website ( www.iconiclabs.co.uk)

Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed

Page 1 of 2

inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.ukor contact:

John Quinlan	Iconic Labs Plc		c/o SBP Tel: [phone]
				1177
Damon Heath	Shard	Capital	Partners	Tel: [phone]
	LLP
Hugo de Salis	St	Brides	Partners	Tel: [phone]
	Limited
David Penson	St	Brides	Partners	Tel: [phone]
	Limited

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please [e-mail] visit www.rns.com.

END

RAGWGGWPPUPBGUG

Page 2 of 2